Neuroimaging Study

Overview

About this study

The purpose of this study is to gather information and learn more about imaging tests in racially different people who are cognitively normal or have dementia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Male or female African Americans 30 years of age or older

- Subjects who have completed or are scheduled to undergo the neurological evaluation
procedures described below.

Exclusion Criteria:

- Subjects unable to lie down without moving for 20 minutes.

- Women who are pregnant or cannot stop breast feeding for 24 hours.

- Claustrophobic patients unable to tolerate the scans.

- Subjects with a prolonged QT interval (as demonstrated by ECG test) cannot participate
in the Tau-PET scans.

- Standard safety exclusionary criteria for MRI such as metallic foreign bodies,
pacemaker, etc, since the quantitative PET data analysis is based on anatomic criteria
that are established uniquely for each subject by registration to his/her MRI.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Neill Graff Radford, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Rochester, Minn.

Mayo Clinic principal investigator

Val Lowe, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Alzheimer’s Disease Research Center

(507) 284-1324

More information

Publications

Publications are currently not available
.
CLS-20438426

Mayo Clinic Footer